Segment Information

9 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Segment Information

(11)        Segment Information

The Company has five reportable segments which include: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended September 30,				Nine months ended September 30,
Sale of Product	2019		2018		2019		2018
Radiochemical Products	$	936,656	$	471,734	$	2,173,995	$	1,657,619
Cobalt Products		97,849		1,104,462		687,177		1,757,008
Nuclear Medicine Standards		1,022,291		957,632		3,053,909		2,922,419
Radiological Services		280,692		146,932		1,086,098		1,537,046
Fluorine Products		—		—		—		—
Total Segments		2,337,488		2,680,760		7,001,179		7,874,092
Corporate revenue		—		—		—
Total Consolidated	$	2,337,488	$	2,680,760	$	7,001,179	$	7,874,092

	Three months ended September 30,				Nine months ended September 30,
Depreciation and Amortization	2019		2018		2019		2018
Radiochemical Products	$	9,892	$	7,507	$	27,978	$	18,567
Cobalt Products		1,269		1,021		3,371		5,817
Nuclear Medicine Standards		15,954		16,184		47,246		50,652
Radiological Services		8,636		11,290		25,908		35,247
Fluorine Products		28,465		28,423		85,367		85,243
Total Segments		64,216		64,425		189,870		195,526
Corporate depreciation and amortization		2,394		2,396		7,184		7,381
Total Consolidated	$	66,610	$	66,821	$	197,054	$	202,907

	Three months ended September 30,						Nine months ended September 30,
Segment Income (Loss)	2019			2018			2019			2018
Radiochemical Products	$	331,988		$	53,101		$	680,990		$	196,658
Cobalt Products		38,517			238,182			353,639			516,087
Nuclear Medicine Standards		180,828			164,759			509,571			553,995
Radiological Services		482,414			27,020			(107,541	)		593,473
Fluorine Products		(36,026	)		(29,865	)		(113,448	)		(92,777	)
Total Segments		997,721			453,197			1,323,211			1,767,436
Corporate loss		(761,259	)		(786,419	)		(2,295,900	)		(2,398,533	)
Net Income (Loss)	$	236,462		$	(333,222	)	$	(972,689	)	$	(631,097	)

	Three months ended September 30,				Nine months ended September 30,
Expenditures for Segment Assets	2019		2018		2019		2018
Radiochemical Products	$	3,994	$	15,120	$	18,839	$	54,475
Cobalt Products		47,338		—		50,831		—
Nuclear Medicine Standards		1,750		569		6,700		22,630
Radiological Services		—		—		—		—
Fluorine Products		—		—		1,589		1,560
Total Segments		53,082		15,689		77,959		78,665
Corporate purchases		—		—		—		—
Total Consolidated	$	53,082	$	15,689	$	77,959	$	78,665

	September 30,		December 31,
Segment Assets	2019		2018
Radiochemical Products	$	324,404	$	344,994
Cobalt Products		3,273,835		2,611,939
Nuclear Medicine Standards		2,173,871		2,113,960
Radiological Services		101,267		281,077
Fluorine Products		5,506,274		5,590,053
Total Segments		11,379,651		10,942,023
Corporate assets		3,485,548		2,048,053
Total Consolidated	$	14,865,199	$	12,990,076